942145-77-9 Usage
General Description
Azepino[4,5-b]indole-5-carboxylic acid, 1,2,3,6-tetrahydro-1,1-dimethyl-, 1-methylethyl ester is a chemical compound that belongs to the class of indole derivatives. It is commonly used as an intermediate in the synthesis of pharmaceutical drugs and other organic compounds. This chemical compound can be used in the production of various medications, including those used for the treatment of neurological disorders, cancer, and infectious diseases. Additionally, it may also have potential applications in the fields of agricultural chemicals and materials science. Overall, this chemical compound has versatile applications and plays a crucial role in the development of new drug compounds and other important products.
Check Digit Verification of cas no
The CAS Registry Mumber 942145-77-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,2,1,4 and 5 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 942145-77:
(8*9)+(7*4)+(6*2)+(5*1)+(4*4)+(3*5)+(2*7)+(1*7)=169
169 % 10 = 9
So 942145-77-9 is a valid CAS Registry Number.
InChI:InChI=1/C18H22N2O2/c1-11(2)22-17(21)13-9-19-10-18(3,4)15-12-7-5-6-8-14(12)20-16(13)15/h5-9,11,19-20H,10H2,1-4H3
942145-77-9Relevant articles and documents
Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR)
Flatt, Brenton,Martin, Richard,Wang, Tie-Lin,Mahaney, Paige,Murphy, Brett,Gu, Xiao-Hui,Foster, Paul,Li, Jiali,Pircher, Parinaz,Petrowski, Mary,Schulman, Ira,Westin, Stefan,Wrobel, Jay,Yan, Grace,Bischoff, Eric,Daige, Chris,Mohan, Raju
supporting information; experimental part, p. 904 - 907 (2009/12/24)
Azepino[4,5-b]indoles have been identified as potent agonists of the farnesoid X receptor (FXR). In vitro and in vivo optimization has led to the discovery of 6m (XL335, WAY-362450) as a potent, selective, and orally bioavailable FXR agonist (EC50 = 4 nM, Eff = 149%). Oral administration of 6m to LDLR-/- mice results in lowering of cholesterol and triglycerides. Chronic administration in an atherosclerosis model results in significant reduction in aortic arch lesions.